Skip Navigation

Close and don't show again.

Your browser is out of date.

You may not get the full experience here on National Journal.

Please upgrade your browser to any of the following supported browsers:

A Batch of Pricey Drugs Goes Generic A Batch of Pricey Drugs Goes Generic

This ad will end in seconds
 
Close X

Not a member? Learn More »

Forget Your Password?

Don't have an account? Register »

Reveal Navigation
 

 

Health Care / health care

A Batch of Pricey Drugs Goes Generic

A doctor writes prescriptions for drugs. A batch of expensive prescription drugs are about to go generic.(File photo by Jessica Marcy/KHN)

October 24, 2011

Some of the most popular and expensive brand-name drugs are about to go generic, Kaiser Health News reports. 

In November, the cholesterol drug Lipitor drug comes off-patent, and by next June, there are likely to be multiple generic versions.

With almost $11 billion in sales last year, it's the largest blockbuster to fall off what analysts call the "patent cliff." And it's just one of dozens of popular high-end pharmaceuticals whose prices are expected to plummet in the coming years, including drugs such as Plavix for heart disease, Seroquel for depression, and Nexium for heartburn.

 

Patients often pay more for name-brand drugs, even when they're covered by insurance. Sometimes they have no choice because, unlike Lipitor, many drugs don't yet have generic competition. 

Cardiologist Howard Weintraub of New York University says many patients taking those drugs come in and beg for free samples. Others simply don't fill their prescriptions—or they do, but then try to stretch their resources by taking the pricey pills less often than they're supposed to.

"People come in with their blood pressure not as well controlled, or they come in and their cholesterol's all of a sudden mysteriously higher. And you realize, OK, the medicine hasn't stopped working, but you also realize the medicine doesn't work when it's still in the bottle," he says.

Generics already represent 70 percent to 80 percent of drug sales—a dominance expected to grow in the future. Michael Kleinrock, of marketing research firm IMS Health, says patent expirations over the last half-decade are one of the main reasons Medicare spent $50 billion less than federal officials projected five years earlier. Kleinrock says the average daily cost of drugs dropped one-third from 2005 to 2010, and should drop another third between now and 2015.

This story is part of a reporting partnership among NPR, Kaiser Health News, and NPR member stations.

LIKE THIS STORY? Sign up for Health Care Edge

Get your daily dose of National Journal's health care coverage.

Sign up form for Health Care Edge
Job Board
Search Jobs
Biomedical Service Internship Position
American Society of Civil Engineers | Flint, MI
Fire Sprinkler Inspector
American Society of Civil Engineers | Charlotte, NC
Professional Development Program Engineer
American Society of Civil Engineers | Farmington Hills, MI
Deputy Director of Transit Operations
American Society of Civil Engineers | San Jose, CA
Transportation Planner
American Society of Civil Engineers | Salinas, CA
Assistant Professor - Water Resources/Ecological Engineering
American Society of Civil Engineers | Auburn, AL
Product Manager - Chemical Development and Supply - Tulsa, OK
American Society of Civil Engineers | Tulsa, OK
Commissioning Intern
American Society of Civil Engineers | Chicago, IL
Assessment and Remediation Team Lead
American Society of Civil Engineers | Regina, SK
Business Development Manager
American Society of Civil Engineers
Sr. Controls Systems Engineer
American Society of Civil Engineers | Grand Island, NE
Senior Project Manager- Transportation
American Society of Civil Engineers | San Antonio, TX
Materials Engineer 2
American Society of Civil Engineers | IL
Land Surveyor
American Society of Civil Engineers
Quality Engineer
American Society of Civil Engineers | Attica, IN
 
Comments
comments powered by Disqus